Finance and Tax Advisory Committee (FTAC)

1. Influence and shape government policy on tax and finance matters to provide the support necessary for our membership and wider industry sector

We will do this by driving and influencing legislative change to protect the sector by:

• Supporting and influencing the Scale-Up Taskforce recommendations
• Addressing HMRC consultations and continue proactive advocacy for our sector

2. Assist with improving the attractiveness of UK biotech companies to investors

Building the funding story for our members by:

• Providing and interpreting meaningful data – capital investment, investment in R&D
• Identifying ways to engage further with the investment community

We will pro-actively engage with HM Treasury/HMRC on anticipated tax changes, particularly capital gains tax and the implementation of the PAYE cap, to ensure the BIA is first in the conversation. We will follow the National Security and Investment Bill and inform the BIA’s representations to Government. We will work with the British Business Bank and Office for Life Sciences, and other partners and stakeholders, to identify actions that could increase the availability of finance for our sector.

3. Continuing to be a sustainable impactful committee, providing a valuable resource for BIA members on finance and tax matters

Supporting our members:

• Supporting the wider membership base: education; information – webinars, guidance notes
• Explore more informal communication channels to support development of wider network participation
• Identify ways of supporting the next generation of finance leaders